Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GF.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
GF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GF.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
GF.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
GF.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
GF.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
GF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GF.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
GF.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
GF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GF.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GF.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GF.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GF.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GF.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
GF.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
EG.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
EG.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
EG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
EG.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
EG.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
EG.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
EG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EG.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
EG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EG.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EG.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EG.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XBB.1.5.24ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XBB.1.5.24ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XBB.1.5.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.24ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.1.5.24ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used